Fatal Dermatological Squeal Following Depot Medroxyprogesterone Acetate (DMPA) Administration: A Catastrophic Hypersensitivity Case Report

The use of depot progesterone as a contraceptive every three months by a considerable number of women has raised concerns regarding the potential for hormones and chemicals to trigger fatal immune responses resulting in skin reactions. The focus of our case report is a 25-year-old woman who suffered a fatal dermatological condition after using this contraceptive. It is noteworthy that this specific condition has not been documented in medical literature before.